Just like bad medicine…Trump tariff pricks again; India not seen badly hit by US’ latest salvo

Just like bad medicine…Trump tariff pricks again; India not seen badly hit by US’ latest salvo

US President Donald Trump’s Friday announcement of a 100% tariff on pharmaceutical products may not affect Indian pharma exports as the measure currently targets only “patented and branded products,” while India predominantly ships generic drugs to the US, experts said. “Because the 100% tariff is targeted at branded/patented drugs, most Indian generic exports would not…

Read More